DE69332276D1 - Liposomenzusammensetzung - Google Patents

Liposomenzusammensetzung

Info

Publication number
DE69332276D1
DE69332276D1 DE69332276T DE69332276T DE69332276D1 DE 69332276 D1 DE69332276 D1 DE 69332276D1 DE 69332276 T DE69332276 T DE 69332276T DE 69332276 T DE69332276 T DE 69332276T DE 69332276 D1 DE69332276 D1 DE 69332276D1
Authority
DE
Germany
Prior art keywords
peyer
glands
liposomes composition
liposomes
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69332276T
Other languages
English (en)
Other versions
DE69332276T2 (de
Inventor
Syuji Sato
Iwao Nozawa
Katsuhiko Akiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of DE69332276D1 publication Critical patent/DE69332276D1/de
Application granted granted Critical
Publication of DE69332276T2 publication Critical patent/DE69332276T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69332276T 1992-04-10 1993-04-09 Liposomenzusammensetzung Expired - Fee Related DE69332276T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11802592 1992-04-10
PCT/JP1993/000460 WO1993020801A1 (en) 1992-04-10 1993-04-09 Liposome composition

Publications (2)

Publication Number Publication Date
DE69332276D1 true DE69332276D1 (de) 2002-10-10
DE69332276T2 DE69332276T2 (de) 2003-01-09

Family

ID=14726206

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332276T Expired - Fee Related DE69332276T2 (de) 1992-04-10 1993-04-09 Liposomenzusammensetzung

Country Status (8)

Country Link
US (1) US5573779A (de)
EP (1) EP0728476B1 (de)
KR (1) KR100217826B1 (de)
AT (1) ATE223204T1 (de)
AU (1) AU668934B2 (de)
CA (1) CA2117769C (de)
DE (1) DE69332276T2 (de)
WO (1) WO1993020801A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9400600A (pt) * 1994-02-17 1995-10-24 Finep Financiadora De Estudos Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos
DE69628909T2 (de) 1995-10-12 2003-12-24 Supergen Inc Liposomformulierung von 5-beta steroiden
AU682805B1 (en) * 1996-03-22 1997-10-16 Biosphere Technologies Inc. Method for inducing a systemic immune response to an antigen
US6117449A (en) * 1996-03-22 2000-09-12 Bio-Sphere Technology, Inc. Method for inducing a systemic immune response to a hepatitis antigen
US6207185B1 (en) * 1996-03-22 2001-03-27 Bio-Sphere Technology Method for inducing a systemic immune response to an HIV antigen
US6015576A (en) * 1997-08-29 2000-01-18 Bio-Sphere Technology, Inc. Method for inducing a systemic immune response to an antigen
US20020136762A1 (en) * 1998-01-14 2002-09-26 See Jackie R. Method for inducing a systemic immune response to an antigen
WO1999065467A1 (en) * 1998-06-16 1999-12-23 See Jackie R Method for introducing a chemical agent into the systemic circulation
US6828306B2 (en) * 2000-07-31 2004-12-07 Ottawa Heart Institute Research Corporation Charged lipid compositions and methods for their use
FR2836043B1 (fr) * 2002-02-15 2004-06-04 Inst Nat Sante Rech Med Vesicules lipidiques, preparation et utilisations
US7875289B2 (en) * 2006-03-30 2011-01-25 The Research Foundation Of State University Of New York Compositions of less immunogenic and long-circulating protein-lipid complexes
US7875288B2 (en) * 2006-03-30 2011-01-25 The Research Foundation Of State University Of New York Method for treating blood coagulation disorders
CA2649528A1 (en) * 2006-04-20 2007-11-01 Tokai University Educational System Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
US20080138351A1 (en) * 2006-08-02 2008-06-12 United Therapeutics Corporation Liposome treatment of viral infections
JP2011518124A (ja) * 2008-03-26 2011-06-23 ユニバーシティ・オブ・オックスフォード 小胞体ターゲッティングリポソーム
KR20120059447A (ko) * 2009-03-27 2012-06-08 더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 콜레스테롤 수준 저하 리포좀
US10617640B2 (en) 2009-07-07 2020-04-14 The Research Foundation For The State University Of New York Phosphoserine containing compositions for immune tolerance induction
US10064922B2 (en) * 2011-10-06 2018-09-04 The Research Foundation For The State University Of New York Compositions and methods for immune tolerance induction
CA3107450A1 (en) 2012-03-29 2013-10-03 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
JP6464142B2 (ja) 2013-03-14 2019-02-06 セラバイオーム，エルエルシー プロバイオティクス生物及び／又は治療剤の標的化胃腸管デリバリー
FR3119325B1 (fr) * 2021-01-29 2023-08-11 Renault Jean Yves Compositions liposomales orales

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2645444A1 (de) * 1976-10-08 1978-04-13 Karl Dr Med Theurer Verfahren zur gewinnung von oral wirksamen arzneimitteln und impfstoffen aus primaer nicht darmwirksamen praeparaten
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4952405A (en) * 1988-10-20 1990-08-28 Liposome Technology, Inc. Method of treating M. avium infection
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
EP0432693A1 (de) * 1989-12-11 1991-06-19 Sumitomo Chemical Company, Limited Für virusinfizierte Zellen cytotoxische Liposomen
JPH03236325A (ja) * 1989-12-11 1991-10-22 Sumitomo Chem Co Ltd ウイルス感染細胞を殺傷するリポソーム
RU94040856A (ru) * 1992-03-03 1996-08-20 Дайити Фармасьютикал Ко. Вакцина для перорального введения

Also Published As

Publication number Publication date
KR100217826B1 (ko) 1999-09-01
EP0728476A4 (de) 1997-09-10
AU668934B2 (en) 1996-05-23
CA2117769A1 (en) 1993-10-11
AU3904193A (en) 1993-11-18
ATE223204T1 (de) 2002-09-15
EP0728476A1 (de) 1996-08-28
EP0728476B1 (de) 2002-09-04
US5573779A (en) 1996-11-12
WO1993020801A1 (en) 1993-10-28
CA2117769C (en) 2003-07-22
DE69332276T2 (de) 2003-01-09
KR950700725A (ko) 1995-02-20

Similar Documents

Publication Publication Date Title
DE69332276D1 (de) Liposomenzusammensetzung
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
IL84835A0 (en) Nasal formulations comprising phospholipids and their preparation
ATE65392T1 (de) In mizellulare phospholipidische partikel eingekapselte antineoplastische anthracyclinmittel.
ES8603264A1 (es) Un procedimiento para coencapsular en vesiculas lipidicas una preparacion de liposoma-farmaco
FI971776A (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
IL122486A (en) Process for making liposome preparation
UA29469C2 (uk) Ліпосомальна фармацевтична композиція для внутрішньовенного введення
DK0699068T3 (da) Reduktion af liposominducerede fysiologiske bivirkninger
ES2077904T3 (es) Obtencion y uso de preparados estables de liposomas en forma de pequeñas particulas.
ATE50499T1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
ES2124328T3 (es) Liposomas que contienen diacetato de clorhexidina o digluconato de clorhexidina.
TR199903192T2 (xx) Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.
PT95697A (pt) Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas
DE69013557D1 (de) An Liposome gekuppelte bioaktive Verbindungen und ihre Verwendung in pharmazeutischen Zubereitungen.
ES2097168T3 (es) Liposomas.
GR3029581T3 (en) Liposomes containing encapsulated proteins, method of preparing them and pharmaceutical and cosmetic preparations containing such liposomes
FR2619505B1 (fr) Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant
AU7404691A (en) Parenterally administrable lipsome formulation comprising synthetic lipids
ATE199315T1 (de) Liposomzubereitungen enthaltend hybrid-interferon

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee